ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
LeftYahoo
|
913 |
303K |
37 |
06/08/23 |
06/08/23 |
ASX - By Stock
|
913
|
303K
|
37
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
LeftYahoo
|
913 |
303K |
17 |
06/08/23 |
06/08/23 |
ASX - By Stock
|
913
|
303K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
LeftYahoo
|
913 |
303K |
138 |
06/08/23 |
06/08/23 |
ASX - By Stock
|
913
|
303K
|
138
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
LeftYahoo
|
4.7K |
1.1M |
28 |
09/02/23 |
09/02/23 |
ASX - By Stock
|
4.7K
|
1.1M
|
28
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
LeftYahoo
|
4.7K |
1.1M |
26 |
08/02/23 |
08/02/23 |
ASX - By Stock
|
4.7K
|
1.1M
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel-L Improves LVEF, Preceding Reduction in MACE
|
|
LeftYahoo
|
299 |
106K |
69 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
299
|
106K
|
69
|
|
ASX - By Stock
|
MSB |
Re:
CHF - MSB's Dark Horse with Multi-billion dollar potential
|
|
LeftYahoo
|
516 |
160K |
37 |
16/07/22 |
16/07/22 |
ASX - By Stock
|
516
|
160K
|
37
|
|
ASX - By Stock
|
MSB |
Re:
CHF - MSB's Dark Horse with Multi-billion dollar potential
|
|
LeftYahoo
|
516 |
160K |
44 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
516
|
160K
|
44
|
|
ASX - By Stock
|
MSB |
Re:
Emergency Access to Rem-L
|
|
LeftYahoo
|
147 |
39K |
26 |
11/08/21 |
11/08/21 |
ASX - By Stock
|
147
|
39K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Emergency Access to Rem-L
|
|
LeftYahoo
|
147 |
39K |
44 |
11/08/21 |
11/08/21 |
ASX - By Stock
|
147
|
39K
|
44
|
|
ASX - By Stock
|
MSB |
Re:
Moderated
|
|
LeftYahoo
|
1.5K |
511K |
8 |
14/07/21 |
14/07/21 |
ASX - By Stock
|
1.5K
|
511K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Moderated
|
|
LeftYahoo
|
1.5K |
511K |
12 |
14/07/21 |
14/07/21 |
ASX - By Stock
|
1.5K
|
511K
|
12
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
LeftYahoo
|
10K |
3.1M |
21 |
01/05/21 |
01/05/21 |
ASX - By Stock
|
10K
|
3.1M
|
21
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
LeftYahoo
|
10K |
3.1M |
44 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
10K
|
3.1M
|
44
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
LeftYahoo
|
10K |
3.1M |
30 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
10K
|
3.1M
|
30
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
LeftYahoo
|
1.6K |
470K |
19 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
1.6K
|
470K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
LeftYahoo
|
1.6K |
470K |
76 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
1.6K
|
470K
|
76
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
LeftYahoo
|
10K |
3.1M |
41 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
10K
|
3.1M
|
41
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
LeftYahoo
|
10K |
3.1M |
8 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
10K
|
3.1M
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
LeftYahoo
|
10K |
3.1M |
8 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
10K
|
3.1M
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
LeftYahoo
|
10K |
3.1M |
19 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
10K
|
3.1M
|
19
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
LeftYahoo
|
10K |
3.1M |
33 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
10K
|
3.1M
|
33
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
LeftYahoo
|
10K |
3.1M |
11 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
10K
|
3.1M
|
11
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
LeftYahoo
|
10K |
3.1M |
19 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
10K
|
3.1M
|
19
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
LeftYahoo
|
10K |
3.1M |
26 |
26/04/21 |
26/04/21 |
ASX - By Stock
|
10K
|
3.1M
|
26
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
LeftYahoo
|
10K |
3.1M |
33 |
25/04/21 |
25/04/21 |
ASX - By Stock
|
10K
|
3.1M
|
33
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
LeftYahoo
|
10K |
3.1M |
23 |
24/04/21 |
24/04/21 |
ASX - By Stock
|
10K
|
3.1M
|
23
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
LeftYahoo
|
10K |
3.1M |
7 |
24/04/21 |
24/04/21 |
ASX - By Stock
|
10K
|
3.1M
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
LeftYahoo
|
10K |
3.1M |
20 |
24/04/21 |
24/04/21 |
ASX - By Stock
|
10K
|
3.1M
|
20
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
LeftYahoo
|
10K |
3.1M |
12 |
23/04/21 |
23/04/21 |
ASX - By Stock
|
10K
|
3.1M
|
12
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
LeftYahoo
|
10K |
3.1M |
3 |
13/04/21 |
13/04/21 |
ASX - By Stock
|
10K
|
3.1M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
LeftYahoo
|
10K |
3.1M |
12 |
13/04/21 |
13/04/21 |
ASX - By Stock
|
10K
|
3.1M
|
12
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
LeftYahoo
|
10K |
3.1M |
9 |
13/04/21 |
13/04/21 |
ASX - By Stock
|
10K
|
3.1M
|
9
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
LeftYahoo
|
10K |
3.1M |
69 |
13/04/21 |
13/04/21 |
ASX - By Stock
|
10K
|
3.1M
|
69
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
LeftYahoo
|
10K |
3.1M |
42 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
10K
|
3.1M
|
42
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
500K |
71 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
1.0K
|
500K
|
71
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
LeftYahoo
|
1.1K |
322K |
43 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
322K
|
43
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
LeftYahoo
|
10K |
3.1M |
53 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
10K
|
3.1M
|
53
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
LeftYahoo
|
18K |
7.1M |
35 |
28/01/21 |
28/01/21 |
ASX - By Stock
|
18K
|
7.1M
|
35
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
LeftYahoo
|
18K |
7.1M |
123 |
27/01/21 |
27/01/21 |
ASX - By Stock
|
18K
|
7.1M
|
123
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
LeftYahoo
|
18K |
7.1M |
12 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
18K
|
7.1M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
LeftYahoo
|
18K |
7.1M |
29 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
18K
|
7.1M
|
29
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
LeftYahoo
|
18K |
7.1M |
49 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
18K
|
7.1M
|
49
|
|
ASX - By Stock
|
MSB |
Re:
Seeking Alpha hatchet job
|
|
LeftYahoo
|
221 |
67K |
21 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
221
|
67K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Seeking Alpha hatchet job
|
|
LeftYahoo
|
221 |
67K |
66 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
221
|
67K
|
66
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
LeftYahoo
|
763 |
329K |
59 |
14/01/21 |
14/01/21 |
ASX - By Stock
|
763
|
329K
|
59
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
LeftYahoo
|
763 |
329K |
84 |
12/01/21 |
12/01/21 |
ASX - By Stock
|
763
|
329K
|
84
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
500K |
89 |
26/12/20 |
26/12/20 |
ASX - By Stock
|
1.0K
|
500K
|
89
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
500K |
34 |
25/12/20 |
25/12/20 |
ASX - By Stock
|
1.0K
|
500K
|
34
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
LeftYahoo
|
1.0K |
500K |
130 |
24/12/20 |
24/12/20 |
ASX - By Stock
|
1.0K
|
500K
|
130
|
|